Marrone Bio Innovations Stock

Marrone Bio Innovations ROE

Delisted

The Return on Equity (ROE) of Marrone Bio Innovations (MBII) as of Jul 26, 2026 is -55.83 %. In the previous year, Return on Equity (ROE) was -0.17 % — a change of 32,984.64% (lower).

ROE

-55.83 %

YoY

32,984.64%

Last updated:

In 2026, Marrone Bio Innovations's return on equity (ROE) was -55.83 %, a 32,984.64% increase from the -0.17 % ROE in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Marrone Bio Innovations Stock analysis

What does Marrone Bio Innovations do? Marrone Bio Innovations Inc is an American company that has been operating in the field of biological pest control since 2006. It was founded by chemist Dr. Pamela Marrone and is headquartered in Davis, California. The company's business model is based on developing safe and effective biological pest control products made from natural ingredients. The aim is to minimize the environmental impact of agriculture. The company is divided into different divisions, including biological plant protection, biological nitrogen fixation, biological weed control, and other products. Some of the well-known products include Regalia®, Venerate®, and Majestene®. Marrone Bio Innovations has gained significance in recent years and is now one of the leading companies in the field of biological pest control. The company works closely with farmers, research institutions, and regulatory authorities to develop and introduce new products, always prioritizing safety and environmental compatibility. Marrone Bio Innovations is one of the most popular companies on Eulerpool.

ROE Details

Decoding Marrone Bio Innovations's Return on Equity (ROE)

Marrone Bio Innovations's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Marrone Bio Innovations's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Marrone Bio Innovations's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Marrone Bio Innovations’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Marrone Bio Innovations stock

Return on Equity (ROE) of Marrone Bio Innovations is -55.83 % in 2026.

Access this data via the Eulerpool API
Get Free API Key

Profitability — Marrone Bio Innovations

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Marrone Bio Innovations